InMed Pharmaceuticals Inc. Stock Toronto S.E.
Equities
IN
CA4576376012
Biotechnology & Medical Research
Sales 2024 * | 7.3M 5.32M | Sales 2025 * | 9.12M 6.66M | Capitalization | 2.52M 1.84M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.35 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.64% |
Latest transcript on InMed Pharmaceuticals Inc.
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Chief Operating Officer | - | 18-11-04 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 22-02-10 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-15 |
Andrew Hull
CHM | Chairman | 61 | 16-09-11 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |